Sexually Transmitted Infections Treatment Guidelines, 2021
Open accessThe DOI matches its Crossref record; 1,459 of the 1,505 references it cites were found in a registry or an index; 371 of the 802 sources its claims cite were checked for support.
Abstract
These guidelines for the treatment of persons who have or are at risk for sexually transmitted infections (STIs) were updated by CDC after consultation with professionals knowledgeable in the field of STIs who met in Atlanta, Georgia, June 11-14, 2019. The information in this report updates the 2015 guidelines. These guidelines discuss 1) updated recommendations for treatment of Neisseria gonorrhoeae, Chlamydia trachomatis, and Trichomonas vaginalis; 2) addition of metronidazole to the recommended treatment regimen for pelvic inflammatory disease; 3) alternative treatment options for bacterial vaginosis; 4) management of Mycoplasma genitalium; 5) human papillomavirus vaccine recommendations and counseling messages; 6) expanded risk factors for syphilis testing among pregnant women; 7) one-time testing for hepatitis C infection; 8) evaluation of men who have sex with men after sexual assault; and 9) two-step testing for serologic diagnosis of genital herpes simplex virus. Physicians and other health care providers can use these guidelines to assist in prevention and treatment of STIs.
Overview
CoChat Summary
TL;DR
These CDC guidelines update the 2015 STI treatment recommendations after expert consultation and systematic literature review, covering prevention, diagnosis, treatment, and special populations. They include updated guidance for gonorrhea, chlamydia, trichomoniasis, pelvic inflammatory disease, bacterial vaginosis, *Mycoplasma genitalium*, HPV vaccination, syphilis screening in pregnancy, hepatitis C testing, sexual assault evaluation, and HSV serology.
Key findings
- Congenital syphilis in the United States increased from 8.4 to 48.5 cases per 100,000 births during 2012–2019, a 477.4% increase.
- Three randomized controlled trials in sub-Saharan Africa found male circumcision reduced HIV acquisition among men by 50%–60%; HPTN 052 found ART for the infected partner decreased HIV transmission to uninfected heterosexual partners by 96%.
- Doxycycline postexposure prophylaxis after unprotected anal sex among MSM and transgender women reduced incident chlamydia and syphilis by 70% and 73%, respectively, but had no effect on gonorrhea.
- Expedited partner therapy trials showed reductions in chlamydia prevalence at follow-up of approximately 20% and gonorrhea of approximately 50%.
Methods
- CDC staff worked with subject matter experts to identify key questions and conduct systematic MEDLINE-based literature reviews for each section of the 2015 guidelines, focused on microbiologic eradication, symptom alleviation, prevention of sequelae, and prevention of transmission.
- Experts presented literature assessments at an in-person meeting in Atlanta, Georgia, June 11–14, 2019; evidence was rated high, medium, or low using USPSTF-style ratings, and draft recommendations underwent peer review and a public webinar before finalization.
- Recommendations for HIV, hepatitis C, cervical cancer screening, STI screening in pregnancy, HPV testing, and HAV/HBV vaccination were developed after reviewing existing published recommendations.
Limitations
- The paper states these guidelines are “a source of clinical guidance rather than prescriptive standards” and that providers should consider each person’s clinical circumstances and local disease prevalence.
- The paper states several evidence gaps, including limited data on doxycycline STI prophylaxis, no long-term data on STI postexposure prophylaxis effects on antimicrobial resistance and the microbiome, and insufficient data to recommend routine anal cancer screening with anal cytology.
- Evident from the text: many recommendations, especially for syphilis treatment, rely on decades of clinical experience and observational data rather than randomized controlled trials; the document is a broad guideline rather than a single primary study with a defined sample or comparator.
Model-written summary of a shortened version of the paper’s full text (it is longer than we read). Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
221 Valid · 41 Not valid · 158 Not checked · 82 Own results and interpretations
At least one cited source doesn’t support this claim or points to a different paper, and none confirmed it — see the verdicts below.
In the paper
“Adherence can be low (48), and prevention of HIV infection, especially among women, has not been demonstrated (47,49).”
§ Sexually Transmitted Infections Treatment Guidelines, 2021 > Clinical Prevention Guidance > Primary Prevention Methods
What the sources say
- Disputedcites [47] Abdool Karim Q, Abdool Karim SS, Frohlich JA,; CAPRISA 004 Trial Group. Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women. Science 2010; 329: 1168– 74. Erratum in: Science 2011;333:524. 10.1126/science.1193748 20643915 PMC3001187 sourceExperimental — accuracy not yet measured
The Results (‘HIV incidence and effectiveness’; page unavailable) report 5.6 HIV infections per 100 women-years with tenofovir gel versus 9.1 with placebo (p=0.017) in a trial of women. The Discussion states that the gel reduced HIV infection by an estimated 39%. Although the authors call for corroboration, their findings directly contradict the claim that prevention had not been demonstrated. (LLM, conf=0.91)
Checked by a reasoning model — may be wrong.
- Not checked — no full text of the sourcecites [49] Delany-Moretlwe S, Lombard C, Baron D, Tenofovir 1% vaginal gel for prevention of HIV-1 infection in women in South Africa (FACTS-001): a phase 3, randomised, double-blind, placebo-controlled trial. Lancet Infect Dis 2018; 18: 1241– 50. 10.1016/S1473-3099(18)30428-6 30507409 source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Disputed
At least one cited source doesn’t support this claim or points to a different paper, and none confirmed it — see the verdicts below.
In the paper
“In addition, nontreponemal test titers might decrease more slowly for persons previously treated for syphilis (594,595).”
§ Sexually Transmitted Infections Treatment Guidelines, 2021 > Syphilis > Primary and Secondary Syphilis
What the sources say
- Could not verifycites [594] Ghanem KG, Erbelding EJ, Wiener ZS, Rompalo AM. Serological response to syphilis treatment in HIV-positive and HIV-negative patients attending sexually transmitted diseases clinics. Sex Transm Infect 2007; 83: 97– 101. 10.1136/sti.2006.021402 16943224 PMC2598600 sourceExperimental — accuracy not yet measured
The Results (page unavailable) mention a history of syphilis infection, but do not compare titre declines by prior treatment history. The paper compares response times by HIV status and syphilis stage; searches for prior treatment and serological response found no passage addressing whether previously treated patients’ titres decline more slowly. (LLM, conf=0.76)
- Disputedcites [595] Seña AC, Wolff M, Martin DH, Predictors of serological cure and serofast state after treatment in HIV-negative persons with early syphilis. Clin Infect Dis 2011; 53: 1092– 9. 10.1093/cid/cir671 21998287 PMC3205200 sourceExperimental — accuracy not yet measured
In Characteristics Associated With Serological Cure (page unavailable), the paper reports that a history of syphilis was not significantly associated with serological cure; the Discussion likewise says it found no association between history of syphilis and serological response. It mentions a prior study finding less seroreversion after repeat infection, but that is not a finding that titers decrease more slowly in previously treated persons. (LLM, conf=0.82)
Checked by a reasoning model — may be wrong.
hedgedstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Could not verify
Some cited sources support this claim and some don’t — read each source’s verdict below.
In the paper
“Available data demonstrate that use of additional doses of benzathine penicillin G, amoxicillin, or other antibiotics do not enhance efficacy of this recommended regimen when used to treat primary and secondary syphilis, regardless of HIV status (591–593).”
§ Sexually Transmitted Infections Treatment Guidelines, 2021 > Syphilis > Primary and Secondary Syphilis
What the sources say
- Not checked — no full text of the sourcecites [591] Rolfs RT, Joesoef MR, Hendershot EF,; The Syphilis and HIV Study Group. A randomized trial of enhanced therapy for early syphilis in patients with and without human immunodeficiency virus infection. N Engl J Med 1997; 337: 307– 14. 10.1056/NEJM199707313370504 9235493 source
- Disputedcites [592] Yang CJ, Lee NY, Chen TC, One dose versus three weekly doses of benzathine penicillin G for patients co-infected with HIV and early syphilis: a multicenter, prospective observational study. PLoS One 2014; 9: e109667. 10.1371/journal.pone.0109667 25286091 PMC4186862 sourceExperimental — accuracy not yet measured
The Discussion (page unavailable) explicitly says that, among HIV-infected patients with early syphilis, one dose of benzathine penicillin G was inferior to three weekly doses for serological response at 12 months—the opposite of the claim about additional doses. The study excluded patients who received other antibiotics, so it does not establish whether adding amoxicillin or other antibiotics helps; it also does not establish the claim regardless of HIV status. (LLM, conf=0.90)
Checked by a reasoning model — may be wrong.
- Partly supportedcites [593] Ganesan A, Mesner O, Okulicz JF,; Infectious Disease Clinical Research Program HIV/STI Working Group. A single dose of benzathine penicillin G is as effective as multiple doses of benzathine penicillin G for the treatment of HIV-infected persons with early syphilis. Clin Infect Dis 2015; 60: 653– 60. 10.1093/cid/ciu888 25389249 PMC6477935 sourceExperimental — accuracy not yet measured
The Factors Associated With Treatment Response section reports similar responses with one versus multiple BPG doses in HIV-infected people with early syphilis. The study does not establish that adding amoxicillin or other antibiotics to the recommended regimen offers no benefit: its “other” regimens were grouped together and could be alternatives rather than additions. Nor do its findings establish the result regardless of HIV status; the Discussion also notes limited power for people with advanced immunosuppression. Page numbers were not available in our copy. (LLM, conf=0.89)
boosted- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Some cited sources support this claim and some don’t — read each source’s verdict below.
In the paper
“Available data demonstrate that additional doses of benzathine penicillin G, amoxicillin, or other antibiotics in early latent syphilis do not enhance efficacy, regardless of HIV status (592,593,609).”
§ Sexually Transmitted Infections Treatment Guidelines, 2021 > Syphilis > Latent Syphilis
What the sources say
- Disputedcites [592] Yang CJ, Lee NY, Chen TC, One dose versus three weekly doses of benzathine penicillin G for patients co-infected with HIV and early syphilis: a multicenter, prospective observational study. PLoS One 2014; 9: e109667. 10.1371/journal.pone.0109667 25286091 PMC4186862 sourceExperimental — accuracy not yet measured
The Results report that three weekly doses of benzathine penicillin G were associated with a higher serological response than one dose in patients with HIV and early syphilis; the Discussion explicitly calls the one-dose regimen inferior at 12 months. This contradicts the claim that additional doses do not enhance efficacy. The study did not test additional amoxicillin or other antibiotics, or patients without HIV. (LLM, conf=0.90)
Checked by a reasoning model — may be wrong.
- Partly supportedcites [593] Ganesan A, Mesner O, Okulicz JF,; Infectious Disease Clinical Research Program HIV/STI Working Group. A single dose of benzathine penicillin G is as effective as multiple doses of benzathine penicillin G for the treatment of HIV-infected persons with early syphilis. Clin Infect Dis 2015; 60: 653– 60. 10.1093/cid/ciu888 25389249 PMC6477935 sourceExperimental — accuracy not yet measured
The Results report similar treatment responses with one versus multiple BPG doses in HIV-infected people with early syphilis. However, the Data Analysis and Definitions section says syphilis stage was not consistently captured, and the study did not establish the claim specifically for early latent syphilis, amoxicillin or other added antibiotics, or people without HIV. The Discussion further limits its conclusion to patients with preserved CD4 counts and low viral loads. (LLM, conf=0.88)
- Not checked — no full text of the sourcecites [609] Rolfs RT, Joesoef MR, Hendershot EF,; The Syphilis and HIV Study Group. A randomized trial of enhanced therapy for early syphilis in patients with and without human immunodeficiency virus infection. N Engl J Med 1997; 337: 307– 14. 10.1056/NEJM199707313370504 9235493 source
boosted- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Disputed
Some cited sources support this claim and some don’t — read each source’s verdict below.
In the paper
“Available data demonstrate that additional doses of benzathine penicillin G, amoxicillin, or other antibiotics in primary and secondary syphilis among persons with HIV infection do not result in enhanced efficacy (592,593,609).”
§ Sexually Transmitted Infections Treatment Guidelines, 2021 > Syphilis > Syphilis Among Persons with HIV Infection
What the sources say
- Disputedcites [592] Yang CJ, Lee NY, Chen TC, One dose versus three weekly doses of benzathine penicillin G for patients co-infected with HIV and early syphilis: a multicenter, prospective observational study. PLoS One 2014; 9: e109667. 10.1371/journal.pone.0109667 25286091 PMC4186862 sourceExperimental — accuracy not yet measured
The Results report that three weekly doses of benzathine penicillin G were independently associated with a higher serological response than one dose in HIV-infected patients with early syphilis. The Discussion says the subgroup results generally favored three doses, except among patients presenting with primary syphilis; the study did not test additional amoxicillin or other antibiotics. These findings contradict the cited sentence’s blanket claim of no enhanced efficacy. (LLM, conf=0.88)
Checked by a reasoning model — may be wrong.
- Partly supportedcites [593] Ganesan A, Mesner O, Okulicz JF,; Infectious Disease Clinical Research Program HIV/STI Working Group. A single dose of benzathine penicillin G is as effective as multiple doses of benzathine penicillin G for the treatment of HIV-infected persons with early syphilis. Clin Infect Dis 2015; 60: 653– 60. 10.1093/cid/ciu888 25389249 PMC6477935 sourceExperimental — accuracy not yet measured
The Results (Factors Associated With Treatment Response; page not provided) found similar serologic responses with one versus multiple BPG doses in HIV-infected people with early syphilis. It also found no improved response for a pooled “other” regimen group, but the Data Analysis and Definitions section says that group combined penicillin derivatives used alone or with BPG and non-penicillin antibiotics. The paper therefore does not establish the claim specifically for additional amoxicillin or each other antibiotic. (LLM, conf=0.83)
- Not checked — no full text of the sourcecites [609] Rolfs RT, Joesoef MR, Hendershot EF,; The Syphilis and HIV Study Group. A randomized trial of enhanced therapy for early syphilis in patients with and without human immunodeficiency virus infection. N Engl J Med 1997; 337: 307– 14. 10.1056/NEJM199707313370504 9235493 source
boosted- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Disputed
264 more claims · 126 with their cited sources checked
Create a free account to see all 502 claims and to verify the 10 references still open.
- Probably not a substantial claim. 72
- It may state two separate claims as one. 188
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“and a reduction of half the risk of perinatal death (RR, 0.50; 95% CI: 0.33-0.84) (5) as long as treatment for GS been administered 30 days before delivery 5.”
From Efectividad del tratamiento de la sífilis gestacional en el último trimestre sobre la incidencia de sífilis congénita: revisión sistemática y metanálisis (2025) · cites this paper as [5]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The strategy of early diagnosis with rapid tests and immediate treatment (on the same day) with at least one dose of benzathine penicillin leads to a reduction of about 98% in the incidence of CS (relative risk (RR), 0.02; 95% confidence interval (CI: 0.00-0.18)”
From Efectividad del tratamiento de la sífilis gestacional en el último trimestre sobre la incidencia de sífilis congénita: revisión sistemática y metanálisis (2025) · cites this paper as [5]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Sexually Transmitted Infections Treatment Guidelines, 2021 > Syphilis > Congenital Syphilis
“a serum quantitative nontreponemal serologic titer that is fourfold§ (or greater) higher than the mother’s titer at delivery (e.g., maternal titer = 1:2, neonatal titer ≥1:8 or maternal titer = 1:8, neonatal titer ≥1:32)¶;”
§ Sexually Transmitted Infections Treatment Guidelines, 2021 > Syphilis > Congenital Syphilis
“a serum quantitative nontreponemal serologic titer equal to or less than fourfold of the maternal titer at delivery (e.g., maternal titer = 1:8, neonatal titer ≤1:16)”
Citations
Cites
Items 401–600 of 1,461
Tatti, S., Swinehart, J. M., Thielert, C., Tawfik, H., Mescheder, A., & Beutner, K. R. (2008) · Obstetrics & Gynecology · doi:10.1097/aog.0b013e3181719b60 · Cited by 150
Seña, A. C., Zhang, X.-H., Li, T., Zheng, H.-P., Yang, B., Yang, L.-G., Salazar, J. C., Cohen, M. S., Moody, M. A., Radolf, J. D., et al. (2015) · BMC Infectious Diseases · doi:10.1186/s12879-015-1209-0 · Cited by 150
Sevelius, J. (2009) · Journal of the Association of Nurses in AIDS Care · doi:10.1016/j.jana.2009.06.001 · Cited by 150
Mitjà, J., Lukehart, S. A., Pokowas, G., Moses, P., Kapa, A., Godornes, C., Robson, J. M. B., Cherian, S., Houinei, W., Kazadi, W., et al. (2014) · The Lancet Global Health · doi:10.1016/s2214-109x(14)70019-1 · Cited by 149
Meites, E., Szilagyi, P. G., Chesson, H. W., et al. (2019) · American Journal of Transplantation · doi:10.1111/ajt.15633 · Cited by 149
A Pooled Analysis of the Effect of Condoms in Preventing HSV-2 Acquisition
Martin, E. T., Krantz, E., Gottlieb, S. L., Magaret, A. S., Langenberg, A., Stanberry, L., Kamb, M., & Wald, A. (2009) · Archives of Internal Medicine · doi:10.1001/archinternmed.2009.177 · Cited by 148
Valaciclovir Versus Acyclovir in the Treatment of First-Episode Genital Herpes Infection
Fife, K. H., Barbarash, R. A., RUDOLPH, T., DeGregorio, B. T., & ROTH, R. (1997) · Sexually Transmitted Diseases · doi:10.1097/00007435-199709000-00007 · Cited by 148
Manifestations and management of lymphogranuloma venereum.
White, J. A. (2009) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0b013e328320a8ae · Cited by 148
Lymphogranuloma Venereum 2015: Clinical Presentation, Diagnosis, and Treatment: Table 1.
Stoner, B. P., & Cohen, S. E. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/civ756 · Cited by 147
Diaz-Mitoma, F. (1998) · JAMA · doi:10.1001/jama.280.10.887 · Cited by 147
National Surveillance of Antimicrobial Resistance in Neisseria gonorrhoeae
Schwarcz, S. K. (1990) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1990.03450110059027 · Cited by 147
Pathela, P., Braunstein, S. L., Blank, S., & Schillinger, J. A. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cit437 · Cited by 146
GOLDEN, M. R., HOGBEN, M., HANDSFIELD, H. H., ST. LAWRENCE, J. S., POTTERAT, J. J., & HOLMES, K. K. (2003) · Sexually Transmitted Diseases · doi:10.1097/00007435-200306000-00004 · Cited by 145
Testing for HCV infection: an update of guidance for clinicians and laboratorians.
(2013) · PubMed · Cited by 145
Doxycycline Prophylaxis for Bacterial Sexually Transmitted Infections
Grant, J. S., Stafylis, C., Celum, C., Grennan, T., Haire, B. G., Kaldor, J. M., Luetkemeyer, A. F., Saunders, J., Molina, J., & Klausner, J. D. (2019) · Clinical Infectious Diseases · doi:10.1093/cid/ciz866 · Cited by 145
Muzny, C. A., Blanchard, E., Taylor, C. M., Aaron, K. J., Talluri, R., Griswold, M. E., Redden, D. T., Luo, M., Welsh, D. A., Van Der Pol, W. J., et al. (2018) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiy243 · Cited by 145
Self-citationSalado-Rasmussen, K., & Jensen, J. S. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/ciu217 · Cited by 145
Infections with Campylobacter jejuni and Campylobacter-like Organisms in Homosexual Men
QUINN, T. C., GOODELL, S. E., FENNELL, C., WANG, S.-P., SCHUFFLER, M. D., HOLMES, K. K., & STAMM, W. E. (1984) · Annals of Internal Medicine · doi:10.7326/0003-4819-101-2-187 · Cited by 145
Clinical Validation of a Test for the Diagnosis of Vaginitis
Gaydos, C. A., Beqaj, S., Schwebke, J. R., Lebed, J., Smith, B., Davis, T. E., Fife, K. H., Nyirjesy, P., Spurrell, T., Furgerson, D., et al. (2017) · Obstetrics & Gynecology · doi:10.1097/aog.0000000000002090 · Cited by 144
Browne, R. (2004) · Sexually Transmitted Infections · doi:10.1136/sti.2003.008532 · Cited by 144
Transmission of hepatitis C virus infection through tattooing and piercing: a critical review.
Tohme, R. A., & Holmberg, S. D. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cir991 · Cited by 144
The accuracy of clinical findings and laparoscopy in pelvic inflammatory disease
Sellors, J. W., Mahony, J. B., Goldsmith, C. H., Rath, D. J., Mander, R., Hunter, B., Taylor, C., Groves, D., Richardson, H., & Chernesky, M. (1991) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(91)90639-9 · Cited by 144
Vulvovaginal Candidiasis Caused by Non-albicans Candida Species: New Insights
Kennedy, M. A., & Sobel, J. D. (2010) · Current Infectious Disease Reports · doi:10.1007/s11908-010-0137-9 · Cited by 143
The impact of antimicrobials on gonococcal evolution
Sánchez-Busó, L., Golparian, D., Corander, J., Grad, Y. H., Ohnishi, M., Flemming, R., Parkhill, J., Bentley, S. D., Unemo, M., & Harris, S. R. (2019) · Nature Microbiology · doi:10.1038/s41564-019-0501-y · Cited by 143
Paz-Bailey, G., Mendoza, M. C. B., Finlayson, T., Wejnert, C., Le, B., Rose, C., Raymond, H. F., & Prejean, J. (2016) · AIDS · doi:10.1097/qad.0000000000001139 · Cited by 143
Sobngwi‐Tambekou, J., Taljaard, D., Lissouba, P., Zarca, K., Puren, A., Lagarde, E., & Auvert, B. (2009) · The Journal of Infectious Diseases · doi:10.1086/597208 · Cited by 142
(2001) · American Journal of Public Health · doi:10.2105/ajph.91.6.965 · Cited by 142
Lymphogranuloma venereum among men who have sex with men. An epidemiological and clinical review
de Vrieze, N. H. N., & de Vries, H. J. C. (2014) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.2014.901169 · Cited by 141
Stockfleth, E., Beti, H., Orasan, R., Grigorian, F., Mescheder, A., Tawfik, H., & Thielert, C. (2008) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2008.08520.x · Cited by 141
Tucker, M. H., Lomas, C. M., Ramchandar, N., & Waldram, J. D. (2017) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2017.01.023 · Cited by 141
Impact of contraceptive initiation on vaginal microbiota
Achilles, S. L., Austin, M. N., Meyn, L. A., Mhlanga, F., Chirenje, Z. M., & Hillier, S. L. (2018) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2018.02.017 · Cited by 138
Meinking, T. L., Serrano, L., Hard, B., Entzel, P., Lemard, G., Rivera, E., & Villar, M. E. (2002) · Archives of Dermatology · doi:10.1001/archderm.138.2.220 · Cited by 138
van der Helm, J. J., Hoebe, C. J. P. A., van Rooijen, M. S., Brouwers, E. E. H. G., Fennema, H. S. A., Thiesbrummel, H. F. J., & Dukers-Muijrers, N. H. T. M. (2009) · Sexually Transmitted Diseases · doi:10.1097/olq.0b013e3181a44b8c · Cited by 138
Nucleic Acid Amplification Tests for Diagnosis of Neisseria gonorrhoeae Oropharyngeal Infections
Bachmann, L. H., Johnson, R. E., Cheng, H., Markowitz, L. E., Papp, J. R., & Hook, E. W. (2009) · Journal of Clinical Microbiology · doi:10.1128/jcm.01581-08 · Cited by 138
Self-citationMSM starting preexposure prophylaxis are at risk of hepatitis C virus infection.
Hoornenborg, E., Achterbergh, R. C. A., Schim van der Loeff, M. F., Davidovich, U., Hogewoning, A., de Vries, H. J. C., Schinkel, J., Prins, M., & van de Laar, T. J. W. (2017) · AIDS · doi:10.1097/qad.0000000000001522 · Cited by 137
Azithromycin-resistant syphilis infection: San Francisco, California, 2000–2004.
Mitchell, S. J., Engelman, J., Kent, C. K., Lukehart, S. A., Godornes, C., & Klausner, J. D. (2006) · Clinical Infectious Diseases · doi:10.1086/498899 · Cited by 137
Trubiano, J. A., Thursky, K. A., Stewardson, A. J., Urbancic, K., Worth, L. J., Jackson, C., Stevenson, W., Sutherland, M., Slavin, M. A., Grayson, M. L., et al. (2017) · Clinical Infectious Diseases · doi:10.1093/cid/cix244 · Cited by 137
Brettler, D., Mannucci, P., Gringeri, A., Rasko, J., Forsberg, A., Rumi, M., Garsia, R., Rickard, K., & Colombo, M. (1992) · Blood · doi:10.1182/blood.v80.2.540.540 · Cited by 137
Tapsall, J., Read, P., Carmody, C., Bourne, C., Ray, S., Limnios, A., Sloots, T., & Whiley, D. (2009) · Journal of Medical Microbiology · doi:10.1099/jmm.0.007641-0 · Cited by 136
Immunoglobulin prophylaxis for hepatitis A.
Winokur, P. L., & Stapleton, J. T. (1992) · Clinical Infectious Diseases · doi:10.1093/clinids/14.2.580 · Cited by 136
Daley, E. M., Perrin, K. M. K., McDermott, R. J., Vamos, C. A., Rayko, H. L., Packing-Ebuen, J. L., Webb, C., & McFarlane, M. (2010) · Journal of Health Psychology · doi:10.1177/1359105309351249 · Cited by 136
HOOK, E. W., MARTIN, D. H., STEPHENS, J., SMITH, B. S., & SMITH, K. (2002) · Sexually Transmitted Diseases · doi:10.1097/00007435-200208000-00010 · Cited by 135
Wald, A., Carrell, D., Remington, M. L., Kexel, E., Zeh, J., & Corey, L. (2002) · Clinical Infectious Diseases · doi:10.1086/339325 · Cited by 135
Prenatal use of metronidazole and birth defects: no association.
Piper, J. M., Mitchel, E. F., & Ray, W. A. (1993) · PubMed · Cited by 135
Antimicrobial Resistance in Neisseria gonorrhoeae and Treatment of Gonorrhea
Unemo, M., Golparian, D., & Eyre, D. W. (2019) · Methods in molecular biology · doi:10.1007/978-1-4939-9496-0_3 · Cited by 133
Transmission of hepatitis B to chimpanzees by hepatitis B surface antigen-positive saliva and semen.
Alter, H. J., Purcell, R. H., Gerin, J. L., London, W. T., Kaplan, P. M., McAuliffe, V. J., Wagner, J., & Holland, P. V. (1977) · Infection and Immunity · doi:10.1128/iai.16.3.928-933.1977 · Cited by 133
Early Sexual Experiences and Risk Factors for Bacterial Vaginosis
Fethers, K. A., Fairley, C. K., Morton, A., Hocking, J. S., Hopkins, C., Kennedy, L. J., Fehler, G., & Bradshaw, C. S. (2009) · The Journal of Infectious Diseases · doi:10.1086/648092 · Cited by 133
Dowell, M. E., Ross, P. G., Musher, D. M., Cate, T. R., & Baughn, R. E. (1992) · The American Journal of Medicine · doi:10.1016/0002-9343(92)90574-u · Cited by 133
Rosenberg, M. J., Davidson, A. J., Chen, J. H., Judson, F. N., & Douglas, J. M. (1992) · American Journal of Public Health · doi:10.2105/ajph.82.5.669 · Cited by 133
Pilatz, A. M. E., Hossain, H., Kaiser, R., Mankertz, A., Schüttler, C. G., Domann, E., Schuppe, H., Chakraborty, T., Weidner, W., & Wagenlehner, F. R. A. (2014) · European Urology · doi:10.1016/j.eururo.2014.12.005 · Cited by 133
Sena, A. C., Wolff, M., Martin, D. H., Behets, F., Van Damme, K., Leone, P., Langley, C., McNeil, L., & Hook, E. W. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir671 · Cited by 132
Shimada, Y., Deguchi, T., Nakane, K., et al. (2010) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2010.05.011 · Cited by 132
Epidemiology of Sexually Transmitted Infections in Suspected Child Victims of Sexual Assault
Girardet, R. G., Lahoti, S., Howard, L. A., Fajman, N. N., Sawyer, M. K., Driebe, E. M., Lee, F., Sautter, R. L., Greenwald, E., Beck-Sagué, C. M., et al. (2009) · Pediatrics · doi:10.1542/peds.2008-2947 · Cited by 132
Lindane toxicity: a comprehensive review of the medical literature.
Nolan, K., Kamrath, J., & Levitt, J. (2012) · Pediatric Dermatology · doi:10.1111/j.1525-1470.2011.01519.x · Cited by 130
KNOX, J., TABRIZI, S. N., MILLER, P., PETOUMENOS, K., LAW, M., CHEN, S., & GARLAND, S. M. (2002) · Sexually Transmitted Diseases · doi:10.1097/00007435-200211000-00006 · Cited by 130
Sexual transmission of HCV between spouses.
Tahan, V., Karaca, C., Yildirim, B., Bozbas, A., Ozaras, R., Demir, K., Avsar, E., Mert, A., Besisik, F., Kaymakoglu, S., et al. (2005) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2005.40879.x · Cited by 130
Swipe right: dating website and app use among men who have sex with men.
Badal, H. J., Stryker, J. E., DeLuca, N., & Purcell, D. W. (2018) · AIDS and Behavior · doi:10.1007/s10461-017-1882-7 · Cited by 130
Metsch, L. R., Feaster, D. J., Gooden, L., Schackman, B. R., Matheson, T., Das, M., Golden, M. R., Huffaker, S., Haynes, L. F., Tross, S., et al. (2013) · JAMA · doi:10.1001/jama.2013.280034 · Cited by 130
Crowell, A. L., Sanders-Lewis, K., & Secor, W. E. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.4.1407-1409.2003 · Cited by 129
Etiology of clinical proctitis among men who have sex with men.
Klausner, J. D., Kohn, R., & Kent, C. (2004) · Clinical Infectious Diseases · doi:10.1086/380838 · Cited by 129
Scabies: advances in noninvasive diagnosis.
Micali, G., Lacarrubba, F., Verzì, A. E., Chosidow, O., & Schwartz, R. A. (2016) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0004691 · Cited by 129
Vermeulen, G. M., & Bruinse, H. W. (1999) · BJOG: An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.1999.tb08363.x · Cited by 129
Mustafa, S. S., Conn, K. M., & Ramsey, A. C. (2019) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2019.05.037 · Cited by 128
Permethrin-resistant human head lice, Pediculus capitis, and their treatment.
Yoon, K. S., Gao, J.-R., Lee, S. H., Clark, J. M., Brown, L., & Taplin, D. (2003) · Archives of Dermatology · doi:10.1001/archderm.139.8.994 · Cited by 128
Interventions for treating trichomoniasis in women
Forna, F., & Gülmezoglu, A. M. (2003) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000218 · Cited by 128
Warner, L., Klausner, J. D., Rietmeijer, C. A., Malotte, C. K., O'Donnell, L., Margolis, A. D., Greenwood, G. L., Richardson, D., Vrungos, S., O'Donnell, C. R., et al. (2008) · PLoS Medicine · doi:10.1371/journal.pmed.0050135 · Cited by 128
Brooks, J. P., Edwards, D. J., Blithe, D. L., Fettweis, J. M., Serrano, M. G., Sheth, N. U., Strauss, J. F., Buck, G. A., & Jefferson, K. K. (2017) · Contraception · doi:10.1016/j.contraception.2016.11.006 · Cited by 128
Yudin, M. H., Landers, D. V., Meyn, L. A., & Hillier, S. L. (2003) · Obstetrics and Gynecology · doi:10.1016/s0029-7844(03)00566-0 · Cited by 128
Aragon, T. J., Vugia, D. J., Shallow, S., Samuel, M. C., Reingold, A., Angulo, F. J., & Bradford, W. Z. (2007) · Clinical Infectious Diseases · doi:10.1086/510593 · Cited by 128
Scabies: Molecular Perspectives and Therapeutic Implications in the Face of Emerging Drug Resistance
Mounsey, K. E., Holt, D. C., McCarthy, J., Currie, B. J., & Walton, S. F. (2008) · Future Microbiology · doi:10.2217/17460913.3.1.57 · Cited by 127
Aoki, F. Y., Tyring, S. K., Díaz‐Mitoma, F., Gross, G., Gao, J., & Hamed, K. A. (2005) · Clinical Infectious Diseases · doi:10.1086/498521 · Cited by 127
Decreasing Incidences of Gonorrhea- and Chlamydia-Associated Acute Pelvic Inflammatory Disease
Kamwendo, F., Forslin, L., Bodin, L., et al. (1996) · Sexually Transmitted Diseases · doi:10.1097/00007435-199609000-00007 · Cited by 127
Theel, E. S., Katz, S. S., & Pillay, A. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa176 · Cited by 126
Resistance of Herpes Simplex Virus Infections to Nucleoside Analogues in HIV‐Infected Patients
Levin, M. J., Bacon, T. H., & Leary, J. J. (2004) · Clinical Infectious Diseases · doi:10.1086/422364 · Cited by 126
Reisner, S. L., Deutsch, M. B., Peitzmeier, S. M., White Hughto, J. M., Cavanaugh, T. P., Pardee, D. J., McLean, S. A., Panther, L. A., Gelman, M., Mimiaga, M. J., et al. (2018) · PLoS ONE · doi:10.1371/journal.pone.0190172 · Cited by 126
Doxycycline compared with benzathine penicillin for the treatment of early syphilis.
Ghanem, K. G., Erbelding, E. J., Cheng, W. W., & Rompalo, A. M. (2006) · Clinical Infectious Diseases · doi:10.1086/500406 · Cited by 125
Harding, A. S., & Ghanem, K. G. (2012) · Sexually Transmitted Diseases · doi:10.1097/olq.0b013e31824c0e62 · Cited by 125
Durukan, D., Read, T. R. H., Murray, G. L., Doyle, M. L., Chow, E. P. F., Vodstrcil, L. A., Fairley, C. K., Aguirre, I., Mokany, E., Tan, L. Y., et al. (2019) · Clinical Infectious Diseases · doi:10.1093/cid/ciz1031 · Cited by 125
Syphilis laboratory guidelines: performance characteristics of nontreponemal antibody tests.
Tuddenham, S., Katz, S. S., & Ghanem, K. G. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa306 · Cited by 124
Clinical predictors of endometritis in women with symptoms and signs of pelvic inflammatory disease
Peipert, J. F., Ness, R. B., Blume, J. D., Soper, D. E., Holley, R. L., Randall, H. W., Sweet, R. L., Sondheimer, S. J., Hendrix, S. L., Amortegui, A. J., et al. (2001) · American Journal of Obstetrics and Gynecology · doi:10.1067/mob.2001.113847 · Cited by 124
Pathela, P., Braunstein, S. L., Schillinger, J. A., Shepard, C., Sweeney, M., & Blank, S. (2011) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e318230e1ca · Cited by 124
Nelson, H. D., Cantor, A. G., Wagner, J., Jungbauer, R. M., Fu, R. F., Kondo, K. K., Stillman, L., & Quiñones, A. R. (2020) · Journal of General Internal Medicine · doi:10.1007/s11606-020-06020-9 · Cited by 124
Chow, E. P. F., Read, T. R. H., Wigan, R., Donovan, B. J., Chen, M. Y., Bradshaw, C. S., & Fairley, C. K. (2014) · Sexually Transmitted Infections · doi:10.1136/sextrans-2014-051813 · Cited by 123
Goldstone, S. E., Johnstone, A. A., & Moshier, E. L. (2014) · Diseases of the Colon & Rectum · doi:10.1097/dcr.0000000000000058 · Cited by 123
Extravaginal reservoirs of vaginal bacteria as risk factors for incident bacterial vaginosis.
Marrazzo, J. M., Fiedler, T. L., Srinivasan, S., Thomas, K. K., Liu, C., Ko, D., Xie, H., Saracino, M., & Fredricks, D. N. (2012) · The Journal of Infectious Diseases · doi:10.1093/infdis/jis242 · Cited by 123
Marincovich, B. (2003) · Sexually Transmitted Infections · doi:10.1136/sti.79.2.160 · Cited by 123
Management of Women with Cervicitis
Marrazzo, J. M., & Martin, D. H. (2007) · Clinical Infectious Diseases · doi:10.1086/511423 · Cited by 123
Penile Microbiota and Female Partner Bacterial Vaginosis in Rakai, Uganda
Liu, C. M., Hungate, B. A., Tobian, A. A. R., Ravel, J., Prodger, J. L., Serwadda, D., Kigozi, G., Galiwango, R. M., Nalugoda, F., Keim, P., et al. (2015) · mBio · doi:10.1128/mbio.00589-15 · Cited by 123
Increase in hepatitis A virus infections—United States, 2013–2018.
Foster, M. A., Hofmeister, M. G., Kupronis, B. A., Lin, Y., Xia, G.-L., Yin, S., & Teshale, E. (2019) · MMWR Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6818a2 · Cited by 123
Smith, E. M., Swarnavel, S., Ritchie, J. M., Wang, D., Haugen, T. H., & Turek, L. P. (2007) · Pediatric Infectious Disease Journal · doi:10.1097/inf.0b013e318124a4ae · Cited by 122
Ross, J. D. C., Brittain, C., Cole, M. J., et al. (2019) · The Lancet · doi:10.1016/s0140-6736(18)32817-4 · Cited by 122
Masek, B. J., Arora, N., Quinn, N., Aumakhan, B., Holden, J. P., Hardick, A., Agreda, P. M., Barnes, M., & Gaydos, C. A. (2009) · Journal of Clinical Microbiology · doi:10.1128/jcm.02387-08 · Cited by 122
Schwebke, J. R., & Desmond, R. A. (2007) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2007.02.048 · Cited by 121
Hawkes, S., Matin, N., Broutet, N., & Low, N. (n.d.) · BORIS (University Library Bern) · doi:10.7892/boris.7472 · Cited by 121
Legarth, R. A., Ahlström, M. G., Kronborg, G., Larsen, C. S., Pedersen, C., Pedersen, G., Mohey, R., Gerstoft, J., & Obel, N. (2016) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000000825 · Cited by 121
Mertz, G. J. (1997) · Archives of Internal Medicine · doi:10.1001/archinte.1997.00440240109016 · Cited by 121
Hook III, E. W., Behets, F., Van Damme, K., Ravelomanana, N., Leone, P., Sena, A. C., Martin, D., Langley, C., McNeil, L., & Wolff, M. (2010) · The Journal of Infectious Diseases · doi:10.1086/652239 · Cited by 121
Erard, V., Wald, A., Corey, L., Leisenring, W. M., & Boeckh, M. (2007) · The Journal of Infectious Diseases · doi:10.1086/518938 · Cited by 121
Boric Acid Addition to Suppressive Antimicrobial Therapy for Recurrent Bacterial Vaginosis
Reichman, O., Akins, R., & Sobel, J. D. (2009) · Sexually Transmitted Diseases · doi:10.1097/olq.0b013e3181b08456 · Cited by 120
Ryder, N., Jin, F., McNulty, A. M., Grulich, A., & Donovan, B. J. (2009) · Sexually Transmitted Infections · doi:10.1136/sti.2008.033902 · Cited by 120
Ross, J. D. C. (2006) · Sexually Transmitted Infections · doi:10.1136/sti.2005.017368 · Cited by 118
Practice Bulletin No. 157: Cervical Cancer Screening and Prevention
(2016) · Obstetrics & Gynecology · doi:10.1097/aog.0000000000001263 · Cited by 118
Pathela, P., Braunstein, S. L., Blank, S., Shepard, C., & Schillinger, J. A. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/civ289 · Cited by 118
Adachi, K., Nielsen-Saines, K., & Klausner, J. D. (2016) · BioMed Research International · doi:10.1155/2016/9315757 · Cited by 118
Bevan, C. D., Johal, B. J., Mumtaz, G., Ridgway, G. L., & Siddle, N. C. (1995) · BJOG: An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.1995.tb11294.x · Cited by 117
Lewis, D. A., Sriruttan, C., Muller, E. E., et al. (2013) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkt034 · Cited by 117
Implementation of a pharmacist-led penicillin allergy de-labelling service in a public hospital.
du Plessis, T., Walls, G., Jordan, A., & Holland, D. J. (2019) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dky575 · Cited by 117
Effects of recent sexual activity and use of a diaphragm on the vaginal microflora.
Hooton, T. M., Roberts, P. L., & Stamm, W. E. (1994) · Clinical Infectious Diseases · doi:10.1093/clinids/19.2.274 · Cited by 117
Posavad, C. M., Wald, A., Kuntz, S. R., et al. (2004) · The Journal of Infectious Diseases · doi:10.1086/422755 · Cited by 117
Herbst de Cortina, S., Bristow, C. C., Joseph Davey, D., & Klausner, J. D. (2016) · Infectious Diseases in Obstetrics and Gynecology · doi:10.1155/2016/4386127 · Cited by 117
O’Farrell, N. (2002) · Sexually Transmitted Infections · doi:10.1136/sti.78.6.452 · Cited by 116
Fierer, D. S., Uriel, A. J., Carriero, D. C., Klepper, A., Dieterich, D. T., Mullen, M. P., Thung, S. N., Fiel, M. I., & Branch, A. D. (2008) · The Journal of Infectious Diseases · doi:10.1086/590430 · Cited by 116
Imiquimod 5% cream induced psoriasis: a case report, summary of the literature and mechanism
Patel, U., Mark, N. M., Machler, B. C., et al. (2010) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2010.10124.x · Cited by 116
Mycoplasma Genitalium Among Women With Nongonococcal, Nonchlamydial Pelvic Inflammatory Disease
Haggerty, C. L., Totten, P. A., Astete, S. G., & Ness, R. B. (2006) · Infectious Diseases in Obstetrics and Gynecology · doi:10.1155/idog/2006/30184 · Cited by 115
Kirkcaldy, R. D., Zaidi, A., Hook, E. W., Holmes, K. K., Soge, O., del Rio, C., Hall, G., Papp, J., Bolan, G., & Weinstock, H. S. (2013) · Annals of Internal Medicine · doi:10.7326/0003-4819-158-5-201303050-00004 · Cited by 115
Self-citationGilbert, P., Ciccarone, D., Gansky, S. A., Bangsberg, D. R., Clanon, K., McPhee, S. J., Calderón, S. H., Bogetz, A., & Gerbert, B. (2008) · PLoS ONE · doi:10.1371/journal.pone.0001988 · Cited by 115
Sobngwi-Tambekou, J. L., Taljaard, D., Nieuwoudt, M., Lissouba, P., Puren, A. J., & Auvert, B. (2008) · Sexually Transmitted Infections · doi:10.1136/sti.2008.032334 · Cited by 115
Yuan, T., Fitzpatrick, T., Ko, N.-Y., Cai, Y., Chen, Y., Zhao, J., Li, L., Xu, J., Gu, J., Li, J., et al. (2019) · The Lancet Global Health · doi:10.1016/s2214-109x(18)30567-9 · Cited by 114
Short, V. L., Totten, P. A., Ness, R. B., Astete, S. G., Kelsey, S. F., & Haggerty, C. L. (2009) · Clinical Infectious Diseases · doi:10.1086/594123 · Cited by 114
Addressing Inpatient Beta-Lactam Allergies: A Multihospital Implementation
Blumenthal, K. G., Shenoy, E. S., Wolfson, A. R., Berkowitz, D. N., Carballo, V. A., Balekian, D. S., Marquis, K. A., Elshaboury, R., Gandhi, R. G., Meka, P., et al. (2017) · The Journal of Allergy and Clinical Immunology: In Practice · doi:10.1016/j.jaip.2017.02.019 · Cited by 114
Bleeker, M. C. G., Hogewoning, C. J. A., Voorhorst, F. J., van den Brule, A. J. C., Snijders, P. J. F., Starink, T. M., Berkhof, J., & Meijer, C. J. L. M. (2003) · International Journal of Cancer · doi:10.1002/ijc.11473 · Cited by 113
Hepatitis C virus infection among women giving birth—Tennessee and United States, 2009–2014.
Patrick, S. W., Bauer, A. M., Warren, M. D., Jones, T. F., & Wester, C. (2017) · MMWR Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6618a3 · Cited by 113
Comparison of Acute and Subclinical Pelvic Inflammatory Disease
Wiesenfeld, H. C., Sweet, R. L., Ness, R. B., Krohn, M. A., Amortegui, A. J., & Hillier, S. L. (2005) · Sexually Transmitted Diseases · doi:10.1097/01.olq.0000154508.26532.6a · Cited by 113
Wiesenfeld, H. C., & Manhart, L. E. (2017) · The Journal of Infectious Diseases · doi:10.1093/infdis/jix198 · Cited by 113
Bradshaw, C. S., Morton, A. N., Garland, S. M., Horvath, L. B., Kuzevska, I., & Fairley, C. K. (2005) · Journal of Clinical Microbiology · doi:10.1128/jcm.43.3.1304-1308.2005 · Cited by 113
Vallabhaneni, S., Li, X., Vittinghoff, E., Donnell, D., Pilcher, C. D., & Buchbinder, S. P. (2012) · PLoS ONE · doi:10.1371/journal.pone.0045718 · Cited by 113
ACOG Practice Bulletin No. 82: Management of Herpes in Pregnancy
(2007) · Obstetrics and Gynecology · doi:10.1097/01.aog.0000263902.31953.3e · Cited by 113
LAFFERTY, W. E., HUGHES, J. P., & HANDSFIELD, H. H. (1997) · Sexually Transmitted Diseases · doi:10.1097/00007435-199705000-00007 · Cited by 113
Symptoms, Sites, and Significance of Mycoplasma genitalium in Men Who Have Sex with Men
Read, T. R. H., Murray, G. L., Danielewski, J., Fairley, C. K., Doyle, M. L., Worthington, K., Su, J. P., Mokany, E., Tan, L., Lee, D. M., et al. (2019) · Emerging infectious diseases · doi:10.3201/eid2504.181258 · Cited by 113
Hepatitis C virus screening among children exposed during pregnancy.
Chappell, C. A., Hillier, S. L., Crowe, D., Meyn, L. A., Bogen, D. L., & Krans, E. E. (2018) · PEDIATRICS · doi:10.1542/peds.2017-3273 · Cited by 112
Tong, W. W. Y., Jin, F., McHugh, L. C., Maher, T., Sinclair, B., Grulich, A. E., Hillman, R. J., & Carr, A. (2013) · AIDS · doi:10.1097/qad.0b013e3283633111 · Cited by 112
Endometritis does not predict reproductive morbidity after pelvic inflammatory disease
Haggerty, C. L., Ness, R. B., Amortegui, A. J., et al. (2003) · American Journal of Obstetrics and Gynecology · doi:10.1067/mob.2003.87 · Cited by 112
Tests for Treponemal Antibody in CSF
Jaffe, H. W. (1978) · Archives of Internal Medicine · doi:10.1001/archinte.138.2.252 · Cited by 112
Trichomonas vaginalis infection-associated risk of cervical cancer: a meta-analysis
Yang, S., Zhao, W., Wang, H., Wang, Y., Li, J., & Wu, X. (2018) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2018.06.031 · Cited by 111
Bernstein, K. T., Stephens, S. C., Barry, P. M., Kohn, R., Philip, S. S., Liska, S., & Klausner, J. D. (2009) · Clinical Infectious Diseases · doi:10.1086/648427 · Cited by 111
Acute hepatitis C in HIV-infected men who have sex with men.
Ghosn, J., Pierre‐François, S., Thibault, V, Duvivier, C., Tubiana, R., Simon, A., Valantin, M., Dominguez, S., Caumes, E., & Katlama, C. (2004) · HIV Medicine · doi:10.1111/j.1468-1293.2004.00225.x · Cited by 111
Unemo, M., Salado-Rasmussen, K., Hansen, M., Olsen, A. O., Falk, M., Golparian, D., Aasterød, M., Ringlander, J., Nilsson, C., Sundqvist, M., et al. (2017) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2017.09.006 · Cited by 111
Are You Sure It's Syphilis? A Review of False Positive Serology
Nandwani, R., & Evans, D. T. P. (1995) · International Journal of STD & AIDS · doi:10.1177/095646249500600404 · Cited by 111
Hemmerling, A., Harrison, W., Schroeder, A., Park, J., Korn, A., Shiboski, S., Foster-Rosales, A., & Cohen, C. R. (2010) · Sexually Transmitted Diseases · doi:10.1097/olq.0b013e3181e50026 · Cited by 111
Patil, M., Nagamoti, J., & Metgud, S. (2012) · Journal of Global Infectious Diseases · doi:10.4103/0974-777x.93756 · Cited by 110
Cervical carcinoma rates among young females in the United States.
Benard, V. B., Watson, M., Castle, P. E., & Saraiya, M. (2012) · Obstetrics & Gynecology · doi:10.1097/aog.0b013e31826e4609 · Cited by 110
Arbyn, M., Herbert, A., Schenck, U., Nieminen, P., Jordan, J. A., McGoogan, E., Patnick, J., Bergeron, C., Jj, B., Klinkhamer, P. J. J. M., et al. (2007) · Cytopathology · doi:10.1111/j.1365-2303.2007.00464.x · Cited by 110
Simms, I., Eastick, K., Mallinson, H., Thomas, K., Gokhale, R., Hay, P., Herring, A., & Rogers, P. A. (2003) · Journal of Clinical Pathology · doi:10.1136/jcp.56.8.616 · Cited by 109
Xu, F., Sternberg, M. R., & Markowitz, L. E. (2010) · Sexually Transmitted Diseases · doi:10.1097/olq.0b013e3181db2e18 · Cited by 109
Mølgaard-Nielsen, D., Svanström, H., Melbye, M., Hviid, A., & Pasternak, B. (2016) · JAMA · doi:10.1001/jama.2015.17844 · Cited by 108
Possible non-sexual modes of transmission of human papilloma virus.
Sabeena, S., Bhat, P., Kamath, V., & Arunkumar, G. (2017) · Journal of obstetrics and gynaecology research · doi:10.1111/jog.13248 · Cited by 108
Antonio, M. A. D., Meyn, L. A., Murray, P. J., Busse, B., & Hillier, S. L. (2009) · The Journal of Infectious Diseases · doi:10.1086/598686 · Cited by 108
US Preventive Services Task Force, Curry, S. J., Krist, A. H., Owens, D. K., Barry, M. J., Caughey, A. B., Davidson, K. W., Doubeni, C. A., Epling, J. W., Kemper, A. R., et al. (2018) · JAMA · doi:10.1001/jama.2018.11785 · Cited by 108
Dukers-Muijrers, N. H. T. M., Schachter, J., van Liere, G. A. F. S., Wolffs, P. F. G., & Hoebe, C. J. P. A. (2015) · BMC Infectious Diseases · doi:10.1186/s12879-015-1280-6 · Cited by 107
Wilkinson, D., Tholandi, M., Ramjee, G., & Rutherford, G. W. (2002) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(02)00396-1 · Cited by 107
Abad, C. L., & Safdar, N. (2009) · Journal of Chemotherapy · doi:10.1179/joc.2009.21.3.243 · Cited by 107
Unemo, M., Golparian, D., Potočnik, M., & Jeverica, S. (2012) · Eurosurveillance · doi:10.2807/ese.17.25.20200-en · Cited by 106
Martín-Iguacel, R., Llibre, J. M., Nielsen, H. I., Heras, E., Matas, L., Lugo, R., Clotet, B., & Sirera, G. (2010) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-010-0959-2 · Cited by 106
STD screening of HIV-infected MSM in HIV clinics.
Hoover, K. W., Butler, M., Workowski, K., Carpio, F., Follansbee, S., Gratzer, B., Hare, B., Johnston, B., Theodore, J. L., Wohlfeiler, M., et al. (2010) · Sexually Transmitted Diseases · doi:10.1097/olq.0b013e3181e50058 · Cited by 105
Self-citationGhanem, K. G., Moore, R. D., Rompalo, A. M., Erbelding, E. J., Zenilman, J. M., & Gebo, K. A. (2008) · Clinical Infectious Diseases · doi:10.1086/589295 · Cited by 105
Self-citationMena, L. A., Wang, X., Mroczkowski, T. F., & Martin, D. H. (2002) · Clinical Infectious Diseases · doi:10.1086/343829 · Cited by 105
Preventive Healthcare for Underserved Women: Results of a Prison Survey
Nijhawan, A. E., Salloway, R., Nunn, A. S., Poshkus, M., & Clarke, J. G. (2010) · Journal of Women s Health · doi:10.1089/jwh.2009.1469 · Cited by 105
Longitudinal analysis of bacterial vaginosis: findings from the hiv epidemiology research study
Jamieson, D. (2001) · Obstetrics & Gynecology · doi:10.1016/s0029-7844(01)01525-3 · Cited by 104
Vanhommerig, J. W., Lambers, F. A. E., Schinkel, J., Geskus, R. B., Arends, J. E., van de Laar, T. J. W., Lauw, F. N., Brinkman, K., Gras, L., Rijnders, B. J. A., et al. (2015) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofv115 · Cited by 104
Reisner, S. L., White Hughto, J. M., Pardee, D., & Sevelius, J. (2016) · International Journal of STD & AIDS · doi:10.1177/0956462415602418 · Cited by 104
Deguchi, T., Yasuda, M., Yokoi, S., et al. (2003) · Journal of Infection and Chemotherapy · doi:10.1007/s10156-002-0204-8 · Cited by 104
Results of a UK survey of fatal anaphylaxis after oral amoxicillin
Lee, P., & Shanson, D. (2007) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkm315 · Cited by 104
Recurrent Benign Lymphocytic Meningitis
Shalabi, M., & Whitley, R. J. (2006) · Clinical Infectious Diseases · doi:10.1086/508281 · Cited by 103
Antibiotics for syphilis diagnosed during pregnancy
Walker, G. J. (2001) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001143 · Cited by 103
Biomedical and behavioral outcomes of Keep It Up!: an ehealth HIV prevention program RCT.
Mustanski, B., Parsons, J. T., Sullivan, P. S., Madkins, K., Rosenberg, E., & Swann, G. (2018) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2018.04.026 · Cited by 103
Metronidazole excretion in human milk and its effect on the suckling neonate.
Passmore, C. M., McElnay, J., Rainey, E. A., et al. (1988) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1988.tb03362.x · Cited by 103
Park, I. U., Chow, J. M., Bolan, G., Stanley, M., Shieh, J., & Schapiro, J. M. (2011) · The Journal of Infectious Diseases · doi:10.1093/infdis/jir524 · Cited by 103
Self-citationSun, C. J., Stowers, J., Miller, C., Bachmann, L. H., & Rhodes, S. D. (2015) · AIDS and Behavior · doi:10.1007/s10461-014-0942-5 · Cited by 102
Gross, G., Meyer, K., Pres, H., Thielert, C., Tawfik, H., & Mescheder, A. (2007) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/j.1468-3083.2007.02441.x · Cited by 101
Simons, B. C., Spradling, P. R., Bruden, D. J. T., Zanis, C., Case, S., Choromanski, T. L., Apodaca, M., Brogdon, H. D., Dwyer, G., Snowball, M., et al. (2016) · Journal of Infectious Diseases · doi:10.1093/infdis/jiw142 · Cited by 101
Black, C. M., Driebe, E. M., Howard, L. A., Fajman, N. N., Sawyer, M. K., Girardet, R. G., Sautter, R. L., Greenwald, E., Beck-Sague, C. M., Unger, E. R., et al. (2009) · Pediatric Infectious Disease Journal · doi:10.1097/inf.0b013e31819b592e · Cited by 101
Kapeu, A. S., Luostarinen, T., Jellum, E., Dillner, J., Hakama, M., Koskela, P., Lenner, P., Love, A., Mahlamaki, E., Thoresen, S., et al. (2008) · American Journal of Epidemiology · doi:10.1093/aje/kwn354 · Cited by 101
Infectious correlates of HIV-1 shedding in the female upper and lower genital tracts
Coleman, J. S., Hitti, J., Bukusi, E. A., Mwachari, C., Muliro, A., Nguti, R., Gausman, R., Jensen, S., Patton, D., Lockhart, D., et al. (2007) · AIDS · doi:10.1097/qad.0b013e328012b838 · Cited by 101
Nijmeijer, B. M., Koopsen, J., Schinkel, J., Prins, M., & Geijtenbeek, T. B. (2019) · Journal of the International AIDS Society · doi:10.1002/jia2.25348 · Cited by 100
The psychosocial impact of an abnormal cervical smear result
Drolet, M., Brisson, M., Maunsell, E., Franco, E. L., Coutlée, F., Ferenczy, A., Fisher, W., & Mansi, J. A. (2012) · Psycho-Oncology · doi:10.1002/pon.2003 · Cited by 100
Associations between Mycoplasma genitalium, Chlamydia trachomatis, and pelvic inflammatory disease
Simms, I. (2003) · Sexually Transmitted Infections · doi:10.1136/sti.79.2.154 · Cited by 100
Factors contributing to congenital syphilis cases—New York City, 2010–2016.
Slutsker, J. S., Hennessy, R. R., & Schillinger, J. A. (2018) · MMWR. Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6739a3 · Cited by 100
Tong, M.-L., Lin, L.-R., Liu, G.-L., Zhang, H.-L., Zeng, Y.-L., Zheng, W.-H., Liu, L.-L., & Yang, T.-C. (2013) · PLoS ONE · doi:10.1371/journal.pone.0070102 · Cited by 99
Risk Factors for Cervicitis among Women with Bacterial Vaginosis
Marrazzo, J. M., Wiesenfeld, H. C., Murray, P. J., Busse, B., Meyn, L. A., Krohn, M. A., & Hillier, S. L. (2006) · The Journal of Infectious Diseases · doi:10.1086/500149 · Cited by 99
Cartwright, C. P., Lembke, B. D., Ramachandran, K., Body, B. A., Nye, M. B., Rivers, C. A., & Schwebke, J. R. (2012) · Journal of Clinical Microbiology · doi:10.1128/jcm.00506-12 · Cited by 99
The psychosocial burden of human papillomavirus related disease and screening interventions
Pirotta, M. V., Ung, L., Stein, A., Conway, E. L., Mast, T. C., Fairley, C. K., & Garland, S. M. (2009) · Sexually Transmitted Infections · doi:10.1136/sti.2009.037028 · Cited by 99
Prevalence of bacterial vaginosis in lesbians and heterosexual women in a community setting.
Evans, A. L., Scally, A. J., Wellard, S. J., & Wilson, J. D. (2007) · Sexually Transmitted Infections · doi:10.1136/sti.2006.022277 · Cited by 99
Lusk, M. J., & Koneçny, P. (2008) · Current Opinion in Internal Medicine · doi:10.1097/qco.0b013e3282f3d988 · Cited by 99
Bissessor, M., Tabrizi, S. N., Bradshaw, C. S., Fairley, C. K., Hocking, J. S., Garland, S. M., Twin, J., Poljak, M., Peel, J., & Chen, M. Y. (2016) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2015.11.016 · Cited by 99
Mounsey, K. E., Holt, D. C., McCarthy, J. S., Currie, B. J., & Walton, S. F. (2009) · Archives of Dermatology · doi:10.1001/archdermatol.2009.125 · Cited by 99
Frequent testing of highly sexually active gay men is required to control syphilis.
Gray, R. T., Hoare, A., Prestage, G. P., Donovan, B., Kaldor, J. M., & Wilson, D. P. (2010) · Sexually Transmitted Diseases · doi:10.1097/olq.0b013e3181ca3c0a · Cited by 99
KISSINGER, P. J., Mena, L. A., Levison, J. E., Clark, R. A., Gatski, M., Henderson, H. M., Schmidt, N., Rosenthal, S. L., Myers, L., & Martin, D. H. (2010) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e3181eda955 · Cited by 98
Leone, P. A., Trottier, S., & Miller, J. M. (2002) · Clinical Infectious Diseases · doi:10.1086/339326 · Cited by 98
Crosby, R. A., Charnigo, R. A., Weathers, C., Caliendo, A. M., & Shrier, L. A. (2012) · Sexually Transmitted Infections · doi:10.1136/sextrans-2012-050618 · Cited by 98
Sensitivity and specificity of treponemal-specific tests for the diagnosis of syphilis.
Park, I. U., Tran, A., Pereira, L., & Fakile, Y. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa349 · Cited by 97
Self-citationEvaluating Penicillin Allergies Without Skin Testing
Banks, T. A., Tucker, M. H., & Macy, E. M. (2019) · Current Allergy and Asthma Reports · doi:10.1007/s11882-019-0854-6 · Cited by 97
(2007) · PsycEXTRA Dataset · doi:10.1037/e639302007-001 · Cited by 97
Cherpes, T. L., Wiesenfeld, H. C., Melan, M. A., Kant, J. A., Cosentino, L. A., Meyn, L. A., & Hillier, S. L. (2006) · Sexually Transmitted Diseases · doi:10.1097/01.olq.0000218869.52753.c7 · Cited by 97
International Anal Neoplasia Society Guidelines for the Practice of Digital Anal Rectal Examination
Hillman, R. J., Berry-Lawhorn, J. M., Ong, J. J., Cuming, T., Nathan, M., Goldstone, S. E., Richel, O., Barroso, L. F., Darragh, T. M., Law, C. L. H., et al. (2019) · Journal of Lower Genital Tract Disease · doi:10.1097/lgt.0000000000000458 · Cited by 97
Silverberg, M. J., Ahdieh, L., MUÑOZ, A., Anastos, K., Burk, R. D., Cu‐Uvin, S., Duerr, A. C., Greenblatt, R. M., Klein, R. S., Massad, S. L., et al. (2002) · Sexually Transmitted Diseases · doi:10.1097/00007435-200208000-00001 · Cited by 97
Hepatitis C virus in the semen of men coinfected with HIV-1: prevalence and origin.
Briat, A., Dulioust, E., Galimand, J., Fontaine, H., Chaix, M.-L., Letur-Könirsch, H., Pol, S., Jouannet, P., Rouzioux, C., & Leruez-Ville, M. (2005) · AIDS · doi:10.1097/01.aids.0000189847.98569.2d · Cited by 97
McClelland, R. S., Richardson, B. A., Hassan, W. M., Chohan, V., Lavreys, L., Mandaliya, K., Kiarie, J., Jaoko, W., Ndinya‐Achola, J. O., Baeten, J. M., et al. (2008) · The Journal of Infectious Diseases · doi:10.1086/587490 · Cited by 96
Management of Trichomonas vaginalis in women with suspected metronidazole hypersensitivity
Helms, D. J., Mosure, D. J., Secor, W. E., & Workowski, K. (2008) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2007.10.795 · Cited by 96
Self-citationHowe, K., & KISSINGER, P. J. (2016) · Sexually Transmitted Diseases · doi:10.1097/olq.0000000000000537 · Cited by 96
Research works printed but not linked: 13
- Golden MR, Kerani RP, Stenger M, Effect of expedited partner therapy (EPT) on chlamydial prevalence: the Washington State Community-Level Trial. Presented at the STD Prevention Conference, Minneapolis, MN; March 12–15, 2012.
- Lin JS, Eder M, Bean S. Screening for syphilis infection in pregnant women: a reaffirmation evidence update for the U.S. Preventive Services Task Force. Evidence Synthesis No. 167. AHRQ Publication No. 18-05238-EF-1. Rockville, MD: Agency for Healthcare Research and Quality; 2018. 30234936
- Benton S, Smith J, Wang F, Heitgerd J, Belcher L, Patel H. HIV testing, diagnosis, and linkage to care among persons tested in select CDC-funded health care and non-health care settings, 2012–2017. Presented at the National HIV Prevention Conference, Atlanta, GA: March 18–21, 2019.
- Briggs GC. Drugs in pregnancy and lactation: a reference guide to fetal and neonatal risk. 11th ed. Philadelphia, PA: Wolters Kluwer; 2017.
- Blanco JL, Fuertes I, Bosch J, Effective treatment of lymphogranuloma venereum (LGV) with 1g azithormycin administered weekly for 3 weeks in HIV-infected population. Presented at the Conference on Retroviruses and Opportunist Infections, Seattle, WA; February 23–26, 2015.
- Rolfs RT, Joesoef MR, Hendershot EF,; The Syphilis and HIV Study Group. A randomized trial of enhanced therapy for early syphilis in patients with and without human immunodeficiency virus infection. N Engl J Med 1997; 337: 307– 14. 10.1056/NEJM199707313370504 9235493 · DOI · Paper page
- Ahmed KA, Fox SJ, Frigas E, Park MA. Clinical outcome in the use of cephalosporins in pediatric patients with a history of penicillin allergy. Int Arch Allergy Immunol 2012; 158: 405– 10. 10.1159/000333553 22487723 · DOI · Paper page
- Park IU, Chow JM, Bolan G, Stanley M, Shieh J, Schapiro JM. Screening for syphilis with the treponemal immunoassay: analysis of discordant serology results and implications for clinical management. J Infect Dis 2011; 204: 1297– 304. 10.1093/infdis/jir524 21930610 · DOI · Paper page
- Muzny CA, Blackburn RJ, Sinsky RJ, Austin EL, Schwebke JR. Added benefit of nucleic acid amplification testing for the diagnosis of Trichomonas vaginalis among men and women attending a sexually transmitted diseases clinic. Clin Infect Dis 2014; 59: 834– 41. 10.1093/cid/ciu446 24928292 · DOI · Paper page
- Sobel JD, Nyirjesy P, Brown W. Tinidazole therapy for metronidazole-resistant vaginal trichomoniasis. Clin Infect Dis 2001; 33: 1341– 6. 10.1086/323034 11565074 · DOI · Paper page
- Perkins RB, Guido RS, Castle PE,; 2019 ASCCP Risk-Based Management Consensus Guidelines Committee. 2019 ASCCP risk-based management consensus guidelines for abnormal cervical cancer screening tests and cancer precursors. J Low Genit Tract Dis 2020; 24: 102– 31. 10.1097/LGT.0000000000000525 32243307 PMC7147428 · DOI · Paper page
- Al Jaff DAA, Amin MHM. Comparison of the effectiveness of sulphur ointment, permethrin and oral ivermectin in treatment of scabies. Res J Pharm Biol Chem Sci 2018; 9: 670– 6.
- Chiu S, Argaez C. Ivermectin for parasitic skin infections of scabies: a review of comparative clinical effectiveness, cost-effectiveness, and guidelines. Ottawa, ON: Canadian Agency for Drugs and Technologies in Health; 2019. https://www.ncbi.nlm.nih.gov/books/NBK545083/ 31424718
Cited by
Standards of Care for the Health of Transgender and Gender Diverse People, Version 8
Coleman, E., Radix, A. E., Bouman, W. P., Brown, G. R., de Vries, A. L. C., Deutsch, M. B., Ettner, R., Fraser, L., Goodman, M., Green, J., et al. (2022) · International Journal of Transgender Health · doi:10.1080/26895269.2022.2100644 · Cited by 2,698
Postexposure Doxycycline to Prevent Bacterial Sexually Transmitted Infections
Luetkemeyer, A. F., Donnell, D., Dombrowski, J. C., Cohen, S., Grabow, C., Brown, C. E., Malinski, C., Perkins, R., Nasser, M., Lopez, C., et al. (2023) · New England Journal of Medicine · doi:10.1056/nejmoa2211934 · Cited by 468
Towards a deeper understanding of the vaginal microbiota
France, M., Alizadeh, M., Brown, S., Ma, B., & Ravel, J. (2022) · Nature Microbiology · doi:10.1038/s41564-022-01083-2 · Cited by 382
Miller, J. M., Binnicker, M. J., Campbell, S., Carroll, K. C., Chapin, K. C., Gonzalez, M. D., Harrington, A., Jerris, R. C., Kehl, S. C., Leal, S. M., et al. (2024) · Clinical Infectious Diseases · doi:10.1093/cid/ciae104 · Cited by 376
Diagnosis and Treatment of Sexually Transmitted Infections: A Review
Tuddenham, S., Hamill, M. M., & Ghanem, K. G. (2022) · JAMA · doi:10.1001/jama.2021.23487 · Cited by 302
Metadata
- Authors
- Workowski, K. A., Bachmann, L. H., Chan, P. A., Johnston, C. M., Muzny, C. A., Park, I., Reno, H., Zenilman, J. M., & Bolan, G. A.
- Affiliations
- Emory University (US)
- National Center for HIV/AIDS Viral Hepatitis STD and TB Prevention (US)
- Brown University (US)
- University of Washington (US)
- University of Alabama at Birmingham (US)
- Johns Hopkins University (US)
- Washington University in St. Louis (US)
- Corresponding author
- Workowski, Kimberly A.
- ORCID
- Venue
- MMWR. Recommendations and Reports
- Published
- 2021-07-23
- Volume
- 70
- Issue
- 4
- Pages
- 1-187
- ISSN
- 1057-5987 (ISSN-L)
- 1545-8601
- PMC
- PMC8344968
- OpenAlex
- W3185444663
- Semantic Scholar
- eb300ecb7d38078ce65557d8188da1edbd3174fc
- Cited by
- 3,018
- References
- 1,505
- Citations by year
- 2026: 740 · 2025: 655 · 2024: 606 · 2023: 558 · 2022: 385 · 2021: 64
- FWCI
- 256.76
- Type
- journal article
- Language
- en
- Open access
- diamond
- doi.org
- Licence
- public-domain
- Locations
- MMWR Recommendations and Reports (publishedVersion, public-domain)
- PubMed Central (publishedVersion, public-domain)
- PubMed (publishedVersion)
- Funders
- National Institute of Mental Health (R25MH083620)
- Topics
- Life Sciences › Immunology and Microbiology › Microbiology › Reproductive tract infections research
- Health Sciences › Medicine › Infectious Diseases › HIV/AIDS Research and Interventions
- Health Sciences › Medicine › Epidemiology › Cervical Cancer and HPV Research
- Keywords
- sexually transmitted infections, STI treatment, gonorrhea, Chlamydia trachomatis, Trichomonas vaginalis, pelvic inflammatory disease, bacterial vaginosis, Mycoplasma genitalium, HPV vaccine, HCV screening, HIV prevention
- MeSH terms
- Centers for Disease Control and Prevention, U.S., Humans, Sexually Transmitted Diseases, United States
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
